Press release
AmeraCell Partners with StemWave to Offer Innovative Pain Management Solutions
Fairfax, VA - AmeraCell, a leading provider of life science medicines, is pleased to announce that it has signed a Letter of Intent (LOI) with StemWave, a pioneering provider of non-invasive pain management solutions.
This strategic partnership aims to provide patients with cutting-edge regenerative medicine solutions for pain management, leveraging the expertise of both organizations.
"We are thrilled to partner with StemWave to offer our patients innovative pain management options," said Dr. Doki, Chief Medical Officer of AmeraCell. "This partnership reflects our commitment to providing the most advanced and effective treatments for pain management in Fairfax, Virginia."
"AmeraCell is proud to collaborate with StemWave, a respected leader in pain management," said AJ Pakpour, Founder of AmeraCell. "Together, we will work to improve the lives of patients suffering from chronic pain, offering them new hope and innovative solutions utilizing StemWave therapy in conjunction with our MSC and Exosomes products."
The partnership will enable both organizations to expand their services, providing patients with access to a broader range of regenerative medicine solutions, including stem cell injections and stem cell IV treatments in Fairfax Virginia.
About AmeraCell
AmeraCell is a leading provider of life science medicines with multiple national locations, dedicated to improving the lives of patients through innovative and effective treatments, one cell at a time.
About StemWave
StemWave therapy is a non-invasive treatment that uses acoustic wave technology to stimulate the body's natural healing processes. It is also known as shock wave therapy.
StemWave therapy delivers high-energy sound waves to the affected area, promoting:
- Increased blood flow
- Improved cell regeneration
- Reduced inflammation
Conditions Treated:
StemWave therapy is commonly used to treat musculoskeletal conditions such as:
- Chronic pain
- Plantar fasciitis
- Tendinitis
- Arthritis
- Osteoporosis
Note to editors:
- High-resolution images and interviews with Dr. Doki and AJ Pakpour are available upon request.
- For more information about AmeraCell, please visit
AmeraCell.com
AmeraCellClinics@Gmail.com
407 801 2269
Media Contact
Company Name: AmeraCell
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ameracell-partners-with-stemwave-to-offer-innovative-pain-management-solutions]
Address:3022 Williams Dr
City: Fairfax
State: Virginia 22031
Country: United States
Website: https://ameracell.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AmeraCell Partners with StemWave to Offer Innovative Pain Management Solutions here
News-ID: 3872506 • Views: …
More Releases from ABNewswire
Ilana McBain Launches Limited Edition Fine Art Print Series as Her Profile Rises …
Sunshine Coast artist Ilana McBain has launched a new series of Limited Edition Fine Art Prints featuring 20 variations, each capped at only 100 editions worldwide. Hand-signed, individually numbered, and produced on museum-grade archival paper, the collection reflects McBain's rising profile and growing international collector base. The series showcases her bold, contemporary style and is available now through her online shop.
SUNSHINE COAST, QLD - Australian multidisciplinary artist Ilana McBain today…
Dualentry Explains Why AI Won't Replace Accountants but Will Transform Accountin …
Ask CFOs if artificial intelligence will eliminate their departments, and you'll trigger an immediate defensive reaction.
Of course not; someone needs to ensure compliance, interpret complex standards, make judgment calls. Yet while they're defending their teams, something remarkable is happening: JPMorgan Chase just eliminated 360,000 hours of annual legal document review work with a single AI platform.
PwC announced a $1 billion three-year investment to expand and scale its AI capabilities, including…
Combat Veteran-Physician's MedEq Fitness Empowers Holiday Health Transformations …
MedEq Fitness's complete wellness ecosystem, from hyperbaric chambers to ice plunges, captures holiday market after generating $250,000 in first 90 days. The physician-combat veteran founder's personal long COVID recovery story drives mission to democratize advanced wellness technology.
MedEq Fitness transforms the landscape of home wellness following its remarkable $250,000 revenue generation in just 90 days, as the physician and combat veteran-founded company capitalizes on surging holiday demand for comprehensive health solutions…
Marginal Zone Lymphoma Treatment Pipeline Shows Strong Momentum as 50+ Pharma Co …
DelveInsight's "Marginal Zone Lymphoma Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Marginal Zone Lymphoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download DelveInsight's…
More Releases for AmeraCell
AmeraCell Launches Revolutionary Wharton's Jelly MSc IV Therapy for Advanced Wel …
Image: https://www.abnewswire.com/upload/2025/01/9c6215166ea166a615398ac58e4d78ef.jpg
Fairfax, Virginia - AmeraCell [https://ameracell.com/], a Life Science Clinic, is proud to announce the launch of its groundbreaking Wharton's Jelly MSc IV therapy. This innovative treatment utilizes the regenerative power of Wharton's jelly, cellular solutions, and mesenchymal cells to enhance overall wellness and address various chronic health conditions.
Wharton's Jelly MSc therapy is derived from ethically sourced umbilical cords. It is rich in Wharton's jelly, growth factors, and other bioactive…
AmeraCell Bio Hacking with Wharton's Jelly IV Therapy
Image: https://www.abnewswire.com/upload/2025/01/4403872202ee73139f40540774e54535.jpg
Fairfax Virginia - AmeraCell, [https://ameracell.com/]a leading provider of regenerative medicine solutions, is proud to announce the launch of its innovative Wharton's Jelly IV therapy. This groundbreaking treatment harnesses the power of mesenchymal stem cells (MSCs), cellular solutions, and exosomes to promote overall wellness and address various health conditions.
About Wharton's Jelly IV Therapy
Wharton's Jelly, a gelatinous substance extracted from umbilical cords, is rich in MSCs, growth factors, and other beneficial…
AmeraCell Appoints Renowned Oncologist and Hematologist, Naveen Doki, MD, as Chi …
Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXf6lnWBjHtv1vNESJODCnyAI57Da6r_Bsny_CRL1HkRArIePBqhfHdc8E-3Mgv1srSjvPOZ0kOPN5esunTJVx31kwbLHZ4FGlGNuQxjEUfHP-Zx61Epyfu5917VDsN1YeM0FvdySA?key=pfjRRuJ_S4XBBGPHHK1PXqNz
New York New York - AmeraCell [https://ameracell.com/], a cutting-edge life science company, announced today the appointment of Naveen Doki, MD, as its Chief Medical Officer (CMO). Dr. Doki brings over a decade of experience in oncology and hematology from the DC Metro area to his new role.
As CMO, Dr. Doki will spearhead the development and implementation of AmeraCell's medical strategies, ensuring the company remains at the forefront of regenerative…
AmeraCell Solidifies Leadership in Life Sciences with Plans for Innovation and E …
Image: https://www.abnewswire.com/upload/2025/01/362d0397e292acf147cd220e0ad40f81.jpg
Washington, D.C. - January 2, 2025 - AmeraCell [https://ameracell.com/], a pioneering name in the life sciences sector, is proud to announce its continued success in 2024, solidifying its reputation as an industry leader. With a network of eight strategic locations across the United States, AmeraCell continues to redefine healthcare innovation and deliver exceptional patient outcomes. The company remains dedicated to improving lives through groundbreaking health solutions and personalized care.
Reflecting…
AmeraCell Accessible Affordable Bio Hacking in Katy Texas an American Life Scien …
Image: https://www.abnewswire.com/uploads/c46306625cd5028d1dcf9ba4de05042c.png
Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies.
AmeraCell's Katy location will offer a comprehensive range of life science solutions, including:
- Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise
- Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments…
AmeraCell Bio Hacking in Katy, Texas with Cutting-Edge Life Science Solutions
Image: https://www.abnewswire.com/uploads/79e38f5d5a8c3789b9f55057ecaf6d44.png
Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies.
AmeraCell's Katy location will offer a comprehensive range of life science solutions, including:
- Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise
- Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments…
